Who owns PROCESSA PHARMACEUTICALS INC?
- Ticker: PCSA
- CUSIP Number: 74275c304
Tip: Access positions for across all investors
Analyze quarterly positions in Processa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Processa Pharmaceuticals stock
Who bought or sold PROCESSA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Stonepine Capital Management | 1.0M | $198k | 100% | Sep 2025 |
|
| Geode Capital Management | 303k | $58k | 500% | Sep 2025 |
|
| Vanguard Group | 288k | $55k | 1080% | Sep 2025 |
|
| Virtu Financial | 41k | $8.0k | -61% | Sep 2025 |
|
| Two Sigma Securities | 36k | $7.0k | 100% | Sep 2025 |
|
| Intl Fcstone | 19k | $3.6k | 100% | Sep 2025 |
|
| Sassicaia Capital Advisers | 16k | $3.1k | 100% | Sep 2025 |
|
| Miracle Mile Advisors | 10k | $1.9k | 100% | Sep 2025 |
|
| Tower Research Capital | 2.4k | $458.977400 | -3% | Sep 2025 |
|
| Jones Financial Companies, L.L | 188.00 | $40.006400 | 100% | Sep 2025 |
|
| Wells Fargo & Company | 154.00 | $29.999200 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 2.00 | $0 | 0% | Sep 2025 |
|
Who sold out of Processa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Jun 2025 | 65k | $13k |
| Alpine Partners VI | Jun 2025 | 53k | $11k |
| Cubist Systematic Strategies | Jun 2025 | 42k | $8.6k |
| Jane Street | Jun 2025 | 19k | $4.0k |
| Sequoia Financial Advisors | Jun 2025 | 11k | $2.3k |
| SBI Securities | Jun 2025 | 12.00 | $2.000400 |